GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Now Corp (OTCPK:NWPN) » Definitions » Debt-to-EBITDA

The Now (The Now) Debt-to-EBITDA : N/A (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is The Now Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

The Now's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.23 Mil. The Now's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. The Now's annualized EBITDA for the quarter that ended in Sep. 2015 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for The Now's Debt-to-EBITDA or its related term are showing as below:

NWPN's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.695
* Ranked among companies with meaningful Debt-to-EBITDA only.

The Now Debt-to-EBITDA Historical Data

The historical data trend for The Now's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Now Debt-to-EBITDA Chart

The Now Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Debt-to-EBITDA
Get a 7-Day Free Trial - - -0.10 -0.51 -1.13

The Now Quarterly Data
Dec07 Dec08 Dec09 Dec10 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Sep14 Sep15
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.68 -2.04 -1.37 - N/A

Competitive Comparison of The Now's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, The Now's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Now's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Now's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where The Now's Debt-to-EBITDA falls into.



The Now Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

The Now's Debt-to-EBITDA for the fiscal year that ended in Dec. 2013 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.008 + 45.175) / -42.688
=-1.13

The Now's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2015) EBITDA data.


The Now  (OTCPK:NWPN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


The Now Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of The Now's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


The Now (The Now) Business Description

Traded in Other Exchanges
N/A
Address
3400 Pan American Drive, Unit 53, Miami, FL, USA, 33133
The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.

The Now (The Now) Headlines